{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:23Z","timestamp":1791414143084,"version":"4.3.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"DOI":"10.1093\/jac\/dkaf460","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:21:14Z","timestamp":1764768074000},"source":"Crossref","is-referenced-by-count":1,"title":["<i>In vitro<\/i>\n                    activity of gepotidacin against\n                    <i>Chlamydia trachomatis<\/i>"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-4931","authenticated-orcid":false,"given":"Arabella","family":"Touati","sequence":"first","affiliation":[{"name":"Department of Bacteriology, National Reference Centre for Bacterial Sexually Transmitted Infections, CHU Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-8990","authenticated-orcid":false,"given":"Olivia","family":"Peuchant","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, National Reference Centre for Bacterial Sexually Transmitted Infections, CHU Bordeaux , Bordeaux ,","place":["France"]},{"name":"CNRS, Microbiologie Fondamentale et Pathog\u00e9nicit\u00e9 (MFP), UMR 5334 ARMYNE, Univ. Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase A","family":"Weikel","sequence":"additional","affiliation":[{"name":"Infectious Disease Research, GSK , Collegeville, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-2332","authenticated-orcid":false,"given":"C\u00e9cile","family":"B\u00e9b\u00e9ar","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, National Reference Centre for Bacterial Sexually Transmitted Infections, CHU Bordeaux , Bordeaux ,","place":["France"]},{"name":"CNRS, Microbiologie Fondamentale et Pathog\u00e9nicit\u00e9 (MFP), UMR 5334 ARMYNE, Univ. Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2026011413263525600_dkaf460-B1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"2026011413263525600_dkaf460-B2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1021\/acsinfecdis.8b00315","article-title":"Mechanistic and structural basis for the actions of the antibacterial gepotidacin against Staphylococcus aureus gyrase","volume":"5","author":"Gibson","year":"2019","journal-title":"ACS Infect Dis"},{"key":"2026011413263525600_dkaf460-B3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41579-024-01023-3","article-title":"Antimicrobial treatment and resistance in sexually transmitted bacterial infections","volume":"22","author":"Jensen","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"2026011413263525600_dkaf460-B4","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/jac\/dky162","article-title":"In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae","volume":"73","author":"Jacobsson","year":"2018","journal-title":"J Antimicrobial Chemother"},{"key":"2026011413263525600_dkaf460-B5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","article-title":"Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study","volume":"405","author":"Ross","year":"2025","journal-title":"Lancet"},{"key":"2026011413263525600_dkaf460-B6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1080\/22221751.2020.1775498","article-title":"In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium","volume":"9","author":"Jensen","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2026011413263525600_dkaf460-B7","doi-asserted-by":"publisher","first-page":"e0017923","DOI":"10.1128\/iai.00179-23","article-title":"Neisseria gonorrhoeae drives Chlamydia trachomatis into a persistence-like state during in vitro co-infection","volume":"92","author":"Ball","year":"2024","journal-title":"Infect Immun"},{"key":"2026011413263525600_dkaf460-B8","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1128\/AAC.42.10.2474","article-title":"Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro","volume":"42","author":"Dessus-Babus","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413263525600_dkaf460-B9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1128\/AAC.47.2.636-642.2003","article-title":"Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp","volume":"47","author":"Suchland","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413263525600_dkaf460-B10","doi-asserted-by":"publisher","first-page":"e01221-18","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae","volume":"62","author":"Scangarella-Oman","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf460\/66030914\/dkaf460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf460\/66030914\/dkaf460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:26:43Z","timestamp":1768415203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkaf460\/8384093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf460","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,19]]},"article-number":"dkaf460"}}